Botox competitor awaits approval
The FDA has agreed to evaluate an anti-wrinkle injection treatment from France-based pharmaceutical company Ipsen which if approved would provide a rival for Allergan's Botox.
News & Analysis on Cosmetics Innovation
The FDA has agreed to evaluate an anti-wrinkle injection treatment from France-based pharmaceutical company Ipsen which if approved would provide a rival for Allergan's Botox.
Fake cosmetics flooded into the EU in ever increasing numbers last year although customs officials seized fewer goods overall.